Dynamic Surface Technologies Int.

General Information
Company Name
Dynamic Surface Technologies Int.
Founded Year
1984
Location (Offices)
Founders / Decision Makers
Number of Employees
8
Industries
Industrial, Manufacturing
Funding Stage
-
Social Media

Dynamic Surface Technologies Int. - Company Profile

Dynamic Surface Technologies Int. is a manufacturing company that was founded in 1984. Formerly known as Dynamic Metal Treating, the company specializes in the DYNA-BLUE surface treatment, which adds value to die casting, plastic injection molding, and stamping operations by reducing tool cost. The DYNA-BLUE process is renowned for being the most cost-effective way to decrease wear, corrosion, soldering, heat checking, and washout on dies, with the company offering a guarantee on its efficacy.

As of now, there is no clear information available regarding the headquarters or the last investment made in the company, including the associated investors and the amount of the investment. Despite this, the innovative approach of Dynamic Surface Technologies Int. in the manufacturing industry shows potential for attracting interest from venture capital firms seeking opportunities in this niche.

Funding Rounds & Investors of Dynamic Surface Technologies Int. (0)

View All

There is no investment information

Latest News of Dynamic Surface Technologies Int.

View All

No recent news or press coverage available for Dynamic Surface Technologies Int..

Similar Companies to Dynamic Surface Technologies Int.

View All
BLU3 - Similar company to Dynamic Surface Technologies Int.
BLU3 Go beyond the surface.
Blue Box Air - Similar company to Dynamic Surface Technologies Int.
Blue Box Air A patented process harnessing the power of enzymes to transform the energy profile and indoor air quality of buildings.
Predictive Engineering - Similar company to Dynamic Surface Technologies Int.
Predictive Engineering Experience, Experience, Experience
Surface Ophthalmics - Similar company to Dynamic Surface Technologies Int.
Surface Ophthalmics Developing Next Generation Therapies for Ocular Surface Diseases